Endocrine Abstracts

Aim/hypothesis: Chronic renal failure maintenance hemodialysis (HD) patients are at risk for low bone mineral density (BMD) and fractures. Parathyroid hormone (iPTH) plays a pivotal role in the pathophysiology of uremic bone disease, but in healthy population body weight and particularly body composition are more important determinants of bone mass.Patients and methods: We studied BMD (results were recorded as g/cm2) and T score using D...

Background/Aims: High level of inflammatory cytokines was present within malnourished and chronic renal failure maintenance hemodialysis (MHD) patients, but there were conflicting data about the role of inflammation on development of insulin resistance (IR) in non-obese and overweight MHD patients.Methods: We selected 23 well-nourished and 20 middle- to moderate-malnourished, sex and age-matched, stable MHD patients, 23 male and 20 female, with median di...

Background: We know that lipid profile is disturbed in both subclinical hypothyroidism (SH) and metabolic syndrome (MetSy). In this study we observed lipid profile in newly diagnosed patients with SH and MetSy.Materials and methods: We chose 70 patients (all females) with newly discovered SH and 20 healthy controls, mean age 51.1 (±6.79). The parameters that we determined are: TSH, FT4, anti-TPO-At, triglycerides, whole, LDL and HDL chole...

Background: Recently many authors are questioning the existing of elements of metabolic syndrome (MetSy) in patients with subclinical hypothyroidism (SH). In this cross sectional study we observed glycemia, as an element of MetSy, in newly diagnosed patients with SH.Materials and methods: Seventy females participated in study. Among them there were 50 patients with SH, mean age 58.3 (±8.53), and 20 controls without SH, mean age 51.1 (±6.79). We...

Background and aim: Iron overload and inflammation might participate in the pathogenesis of insulin resistance in community. The improvement of insulin resistance in hemodialysis (HD) patients is frequently seen after correction of anemia. The aim of this study was to investigate the influence of recobinant humam erythropoietin (Epo) treatment on insulin resistance in non-diabetic HD patients.Patients and methods: We investigated the effects of 6 months-...